FDA Approved: MAXITROL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for MAXITROL, a combination ophthalmic antibiotic/steroid, submitted by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis
• Ocular Inflammation

Drugs mentioned

• MAXITROL (Neomycin sulfate, polymyxin B sulfate and dexamethasone; neomycin and polymyxin B sulfates and dexamethasone)

Snippet

SUPPL AP for MAXITROL (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)